4:27 pm Epizyme reports 2013 Collaboration revs of $68.5 mln and net loss of $3.5 mln; sees 2014 R&D expenses of approx. $75 mln and 2014 G&A expenses of approx. $20 mln

4:27 pm Epizyme reports 2013 Collaboration revs of $68.5 mln and net loss of $3.5 mln; sees 2014 R&D expenses of approx. $75 mln and 2014 G&A expenses of approx. $20 mln

more

View todays social media effects on EPZM

View the latest stocks trending across Twitter. Click to view dashboard

See who Epizyme is hiring next, click here to view

Share this post